Imaging methods for detection of chemotherapy-associated cardiotoxicity and dysfunction

Area of Science:

• Oncology
• Cardiology
• Medical Imaging

Background:

• Cancer survival rates have improved significantly.
• Cardiovascular disease is a major cause of long-term morbidity and mortality in cancer survivors.
• Cancer therapies, particularly chemotherapy, can lead to significant cardiac complications.

Purpose of the Study:

• To review imaging techniques for detecting cardiovascular consequences of chemotherapy.
• To differentiate cardiotoxicity and cardiac injury from cardiac dysfunction and cardiomyopathy.
• To discuss current monitoring methods, their limitations, and emerging research in detecting chemotherapy-induced cardiac issues.

Main Methods:

• Review of current literature on cardiovascular complications of chemotherapy.
• Analysis of established and experimental imaging modalities for cardiac assessment.
• Discussion of clinical monitoring strategies and their limitations.

Main Results:

• Chemotherapy can cause various forms of cardiac injury, dysfunction, and cardiomyopathy.
• Current monitoring techniques have limitations in early detection and precise quantification of cardiac damage.
• Novel imaging methods show promise for earlier and more accurate detection of cardiotoxicity.

Conclusions:

• Early detection and monitoring of chemotherapy-induced cardiotoxicity are crucial for managing long-term cancer survivorship.
• Advancements in imaging are essential for improving cardiovascular care in oncology patients.
• Further research into novel techniques will enhance the ability to mitigate cardiac risks associated with cancer treatment.